JP6635927B2 - ノルアドレナリンの安定な低濃度の注射用溶液を生成するための方法 - Google Patents

ノルアドレナリンの安定な低濃度の注射用溶液を生成するための方法 Download PDF

Info

Publication number
JP6635927B2
JP6635927B2 JP2016551222A JP2016551222A JP6635927B2 JP 6635927 B2 JP6635927 B2 JP 6635927B2 JP 2016551222 A JP2016551222 A JP 2016551222A JP 2016551222 A JP2016551222 A JP 2016551222A JP 6635927 B2 JP6635927 B2 JP 6635927B2
Authority
JP
Japan
Prior art keywords
noradrenaline
solution
stable
concentration
inert gas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016551222A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017506632A (ja
Inventor
アウグスト ミティディエリ
アウグスト ミティディエリ
エリザベッタ ドナーティ
エリザベッタ ドナーティ
ニコラ カロンゾーロ
ニコラ カロンゾーロ
Original Assignee
シンテティカ ソシエテ アノニム
シンテティカ ソシエテ アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50693780&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6635927(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by シンテティカ ソシエテ アノニム, シンテティカ ソシエテ アノニム filed Critical シンテティカ ソシエテ アノニム
Publication of JP2017506632A publication Critical patent/JP2017506632A/ja
Application granted granted Critical
Publication of JP6635927B2 publication Critical patent/JP6635927B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04Heat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
JP2016551222A 2014-02-27 2015-02-26 ノルアドレナリンの安定な低濃度の注射用溶液を生成するための方法 Active JP6635927B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20140306 2014-02-27
ITMI2014A000306 2014-02-27
PCT/EP2015/054021 WO2015128418A1 (en) 2014-02-27 2015-02-26 Process for producing a stable low concentration, injectable solution of noradrenaline

Publications (2)

Publication Number Publication Date
JP2017506632A JP2017506632A (ja) 2017-03-09
JP6635927B2 true JP6635927B2 (ja) 2020-01-29

Family

ID=50693780

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016551222A Active JP6635927B2 (ja) 2014-02-27 2015-02-26 ノルアドレナリンの安定な低濃度の注射用溶液を生成するための方法

Country Status (43)

Country Link
US (4) USRE49422E1 (enExample)
EP (1) EP3110399B1 (enExample)
JP (1) JP6635927B2 (enExample)
KR (1) KR102306706B1 (enExample)
CN (1) CN106061467B (enExample)
AP (1) AP2016009467A0 (enExample)
AR (1) AR101148A1 (enExample)
AU (1) AU2015222150B2 (enExample)
BR (1) BR112016019804B1 (enExample)
CA (1) CA2940347C (enExample)
CL (1) CL2016002073A1 (enExample)
CR (1) CR20160420A (enExample)
CY (1) CY1120125T1 (enExample)
DK (1) DK3110399T3 (enExample)
DO (1) DOP2016000210A (enExample)
EA (1) EA031444B1 (enExample)
EC (1) ECSP16065957A (enExample)
ES (1) ES2663817T3 (enExample)
GE (1) GEP20186829B (enExample)
HR (1) HRP20180541T1 (enExample)
HU (1) HUE038738T2 (enExample)
IL (1) IL247501B (enExample)
JO (1) JO3552B1 (enExample)
LT (1) LT3110399T (enExample)
MA (1) MA39200A1 (enExample)
MD (1) MD4628C1 (enExample)
ME (1) ME03004B (enExample)
MX (1) MX367148B (enExample)
MY (1) MY179942A (enExample)
NI (1) NI201600118A (enExample)
PE (1) PE20161375A1 (enExample)
PH (1) PH12016501703B1 (enExample)
PL (1) PL3110399T3 (enExample)
PT (1) PT3110399T (enExample)
RS (1) RS57044B1 (enExample)
SG (1) SG11201607094WA (enExample)
SI (1) SI3110399T1 (enExample)
SM (1) SMT201800239T1 (enExample)
SV (1) SV2016005265A (enExample)
TW (1) TWI673065B (enExample)
UA (1) UA118043C2 (enExample)
UY (1) UY35988A (enExample)
WO (1) WO2015128418A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
PL2990031T3 (pl) 2014-08-28 2020-05-18 Sun Pharmaceutical Industries Ltd Pozajelitowa postać norepinefryny
CA3051467C (en) 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor
US20250177328A1 (en) 2017-01-30 2025-06-05 Nevakar Injectables Inc. Norepinephrine compositions and methods therefor
CN109394683A (zh) * 2018-12-07 2019-03-01 远大医药(中国)有限公司 一种重酒石酸去甲肾上腺素注射液的制备方法
US10888534B2 (en) * 2019-04-26 2021-01-12 InfoRLife SA Storage stable ready-to-use norepinephrine aqueous solutions in flexible plastic bags
CA3174640A1 (en) * 2020-03-06 2021-09-10 Baxter International Inc. Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation
PL4051251T3 (pl) * 2020-10-21 2024-04-08 Sintetica S.A. Stabilne, wolne od antyoksydantów roztwory noradrenaliny do wstrzykiwania
US20220117843A1 (en) * 2020-10-21 2022-04-21 Sintetica S.A. Ready to use, noradrenaline drip bags, having low subvisible particle counts
US11331266B1 (en) * 2020-10-29 2022-05-17 Medefil, Inc. Antioxidant free, norepinephrine bitartrate injection in amber glass vials
US20220233473A1 (en) * 2021-01-28 2022-07-28 Cumberland Pharmaceuticals Inc. Injectable solution of norepinephrine
AR124867A1 (es) 2021-02-15 2023-05-10 Sintetica S A Un medicamento en una bolsa de goteo intravenoso plegable lista para usar herméticamente sellada, método para hacer dicho medicamento y medicamento elaborado mediante dicho método
CN116327697A (zh) * 2023-04-17 2023-06-27 福安药业集团庆余堂制药有限公司 一种重酒石酸去甲肾上腺素注射液及其制剂工艺

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
FR2832063B1 (fr) * 2001-11-15 2004-08-27 Aguettant Lab Procede de production de solutions stables de substances phenoliques et les solutions en resultant
BR0311965A (pt) 2002-06-20 2005-03-29 Novalar Pharmaceutical Inc Formulações estabilizadas de antagonistas de receptores alfa adrenérgicos e os seus usos
US20040005401A1 (en) 2002-07-05 2004-01-08 Robert Becker Method for applying a washcoat to suppport bodies
US7078876B2 (en) 2003-07-07 2006-07-18 Pentadyne Power Corporation Feedforward controller for synchronous reluctance machines
FR2880807B1 (fr) * 2005-01-19 2007-04-13 Aguettant Sa Lab Composition pharmaceutique injectable
US7465489B2 (en) 2005-11-15 2008-12-16 Poly-Med, Inc. Inorganic-organic melted-extruded hybrid filaments and medical applications thereof
FR2894154B1 (fr) 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.
EP2096433A1 (de) 2008-02-26 2009-09-02 Siemens Aktiengesellschaft Vorrichtung zur zerstörungsfreien Materialprüfung eines Prüfgegenstands mit Ultraschallwellen
US8419689B2 (en) 2008-09-30 2013-04-16 Covidien Lp Enclosing package for medical port and cover
CN102802668A (zh) * 2009-06-04 2012-11-28 Alk股份公司 包含至少一种肾上腺素能化合物的稳定化组合物
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
FR2963237B1 (fr) 2010-07-28 2013-05-17 Aguettant Lab Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
CN102525895B (zh) 2012-01-04 2013-11-06 上海禾丰制药有限公司 重酒石酸去甲肾上腺素注射液及其制剂工艺
UY35988A (es) 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
US20160005871A1 (en) 2014-07-04 2016-01-07 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device
CA3051467C (en) 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor

Also Published As

Publication number Publication date
US20170049720A1 (en) 2017-02-23
PL3110399T3 (pl) 2018-07-31
KR102306706B1 (ko) 2021-09-30
DOP2016000210A (es) 2016-11-30
AR101148A1 (es) 2016-11-30
USRE49443E1 (en) 2023-03-07
TWI673065B (zh) 2019-10-01
ECSP16065957A (es) 2017-01-31
MD4628B1 (ro) 2019-05-31
EP3110399A1 (en) 2017-01-04
MA39200A1 (fr) 2017-06-30
HUE038738T2 (hu) 2018-11-28
CL2016002073A1 (es) 2017-02-10
EA201691734A1 (ru) 2016-12-30
EA031444B1 (ru) 2019-01-31
USRE49555E1 (en) 2023-06-20
LT3110399T (lt) 2018-04-25
GEP20186829B (en) 2018-02-26
SMT201800239T1 (it) 2018-07-17
MY179942A (en) 2020-11-19
PH12016501703B1 (en) 2019-08-23
CN106061467B (zh) 2021-02-05
BR112016019804A2 (enExample) 2017-08-15
AU2015222150A1 (en) 2016-10-13
CA2940347C (en) 2021-04-27
ME03004B (me) 2018-10-20
MD4628C1 (ro) 2019-12-31
JP2017506632A (ja) 2017-03-09
AP2016009467A0 (en) 2016-09-30
CN106061467A (zh) 2016-10-26
CA2940347A1 (en) 2015-09-03
WO2015128418A1 (en) 2015-09-03
SV2016005265A (es) 2017-01-18
US10251848B2 (en) 2019-04-09
MX2016011148A (es) 2016-12-09
PH12016501703A1 (en) 2016-12-19
JO3552B1 (ar) 2020-07-05
MX367148B (es) 2019-08-07
KR20160122264A (ko) 2016-10-21
BR112016019804B1 (pt) 2022-03-03
EP3110399B1 (en) 2018-01-10
ES2663817T3 (es) 2018-04-17
SG11201607094WA (en) 2016-09-29
SI3110399T1 (en) 2018-05-31
AU2015222150B2 (en) 2019-12-05
HRP20180541T1 (hr) 2018-05-04
CR20160420A (es) 2016-12-14
RS57044B1 (sr) 2018-05-31
DK3110399T3 (en) 2018-04-09
MD20160103A2 (ro) 2017-01-31
UY35988A (es) 2015-09-30
TW201620499A (zh) 2016-06-16
UA118043C2 (uk) 2018-11-12
CY1120125T1 (el) 2018-12-12
PE20161375A1 (es) 2017-01-05
IL247501A0 (en) 2016-11-30
IL247501B (en) 2020-05-31
NI201600118A (es) 2016-10-03
USRE49422E1 (en) 2023-02-21
PT3110399T (pt) 2018-04-19

Similar Documents

Publication Publication Date Title
JP6635927B2 (ja) ノルアドレナリンの安定な低濃度の注射用溶液を生成するための方法
US9283197B1 (en) More potent and less toxic formulations of epinephrine and methods of medical use
CN1368891A (zh) 莫西沙星/氯化钠制剂
EP2307056A2 (en) Stabilized aqueous formulation containing paracetamol
US10039728B1 (en) More potent and less toxic formulations of epinephrine and methods of medical use
JP2018509462A (ja) タペンタドールの非経口投与のための安定な製剤
JP4959335B2 (ja) メチルフェニデート溶液および関連する投与および製造方法
CN108324683A (zh) 一种稳定的大输液依达拉奉注射液及其制备工艺
US10004700B1 (en) More potent and less toxic formulations of epinephrine and methods of medical use
EP2804597B1 (en) Aqueous paracetamol composition for injection
EP2170313A2 (en) Aqueous formulations of acetaminophen for injection
CN1430510A (zh) α-2,4-二磺基苯基-N-叔丁基硝酮的新制剂
WO2009081283A2 (en) Aqueous formulations of acetaminophen for injection
CN112438948A (zh) 一种间苯三酚组合物及制备方法
WO2019150381A1 (en) A stable pharmaceutical composition and process for production of isoproterenol hydrochloride injection
OA17920A (en) Process for producing a stable low concentration, injectable solution of noradrenaline.
US20240024260A1 (en) Isoproterenol compositions and methods
CN118831047A (zh) 一种盐酸多巴酚丁胺注射液的组成及其制备方法
JP2019529442A (ja) タペンタドールの非経口投与用安定製剤

Legal Events

Date Code Title Description
A529 Written submission of copy of amendment under article 34 pct

Free format text: JAPANESE INTERMEDIATE CODE: A529

Effective date: 20161007

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20170707

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20170707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20170707

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180904

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190204

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20191024

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20191113

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191203

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191217

R150 Certificate of patent or registration of utility model

Ref document number: 6635927

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250